Recombinant Viral Vectors And Methods For Inducing An Immune Response To Yellow Fever Virus

Abstract

The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to yellow fever virus. The invention provides recombinant viral vectors based on the non-replicating modified vaccinia virus Ankara or based on a D4R-defective vaccinia virus. When administered according to methods of the invention, the recombinant viral vectors induce a broad immune response to yellow fever virus and demonstrate an excellent safety profile.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 29, 2012
  • Application: Sep 22, 2011
    WO US 2011/0052773 W
  • Priority: Sep 23, 2010
    US US 38585810 P

Sign in to the Lens

Feedback